Copper, [29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, [[3-(cyclohexylamino)propyl]amino]sulfonyl derivs.

Eye irritation

Administrative data

Endpoint:

eye irritation: in vitro / ex vivo

Type of information:

experimental study

Adequacy of study:

key study

Study period:

From 2017-04-12 to 2017-04-12

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

guideline study

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

2017

Report date:

2017

Materials and methods

Test guideline

Test guideline 1

Qualifier:

according to guideline

Guideline:

OECD Guideline 438 (Isolated Chicken Eye Test Method for Identifying i) Chemicals Inducing Serious Eye Damage and ii) Chemicals Not Requiring Classification for Eye Irritation or Serious Eye Damage)

Deviations:

yes

Remarks:

The eyes were incubated between 55 and 70 minutes instead of between 45 and 60 minutes, as initially scheduled. This deviation is considered as without impact on the conclusion of the study.

Test guideline 2

Qualifier:

according to guideline

Guideline:

EU method B.48 (Isolated chicken eye test method for identifying occular corrosives and severe irritants)

Deviations:

yes

Remarks:

The eyes were incubated between 55 and 70 minutes instead of between 45 and 60 minutes, as initially scheduled. This deviation is considered as without impact on the conclusion of the study.

GLP compliance:

yes (incl. QA statement)

Test material

Test material information

1

Reference substance name:

Copper, [29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, [[3-(cyclohexylamino)propyl]amino]sulfonyl derivs.

EC Number:

309-627-7

EC Name:

Copper, [29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, [[3-(cyclohexylamino)propyl]amino]sulfonyl derivs.

Cas Number:

100545-46-8

Molecular formula:

C32H16-τN8Cu.(SO3)m.(SO3H)p.(C9H19N2SO2)O.(C9H20N2SO2)n

IUPAC Name:

Copper, [29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, [[3-(cyclohexylamino)propyl]amino]sulfonyl derivs.

Test material form:

solid: particulate/powder

Specific details on test material used for the study:

STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: room temperature

Test animals / tissue source

Species:

other: Eyes of chickens

Details on test animals or tissues and environmental conditions:

SOURCE OF COLLECTED EYES
- Source: slaughterhouse (Etablissement Brun, 33820 Etauliers, France), chicken killed for human consumption have been used for this assay.
- Number of animals: 7 eyes
- Characteristics of donor animals (e.g. age, sex, weight): spring chickens traditionally processed by a poultry slaughterhouse (i.e., approximately 7 weeks old, 1.5 - 2.5 kg).
- Storage, temperature and transport conditions of ocular tissue (e.g. transport time, transport media and temperature, and other conditions):
* transport time : 1h35
* transport temperature : ambient temperature
* transport conditions : in plastic boxes humidified with towels moistened with physiological saline.
- Time interval prior to initiating testing:
1h35 for the enucleation,
55 and 70 minutes to equilibrate them to the test system prior to dosing, once all eyes had been examined and approved

Test system

Vehicle:

unchanged (no vehicle)

Controls:

yes, concurrent vehicle

yes, concurrent positive control

Amount / concentration applied:

TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 30 mg, (powder, as supplied)

Duration of treatment / exposure:

10 seconds

Number of animals or in vitro replicates:

Test item: 3 replicates
Concurrent negative control : 1 replicate
Concurrent positive control : 3 replicates

Details on study design:

SELECTION AND PREPARATION OF ISOLATED EYES
The eyelids were carefully excised, taking care not to damage the cornea. Then, the eye was further dissected from the skull, taking care not to damage the cornea. The eyeball was pulled from the orbit by holding the nictitating membrane firmly with surgical forceps, and the eye muscles were cut with a
bent, blunt-tipped scissor. When the eye is removed from the orbit, a visible portion of the optic nerve should be left attached. Once removed from the orbit, the eye was placed on an absorbent pad and the nictitating membrane and other connective tissue were cut away.

The enucleated eye was mounted in a stainless steel clamp with the cornea positioned vertically. The clamp was then transferred to a chamber of the superfusion apparatus. The clamps were positioned in the superfusion apparatus such that the entire cornea was supplied with the physiological saline drip
(in the range 0.1 to 0.15 mL/min). The chambers of the superfusion apparatus was temperature controlled between 31.6°C and 32.4°C.

After being placed in the superfusion apparatus, the eyes were examined with a slit-lamp microscope to ensure that they have not been damaged during the dissection procedure. Corneal thickness was also measured at this time at the corneal apex using the depth measuring device on the slit-lamp
microscope. Eyes with; (i), a fluorescein retention score of > 0.5; (ii) corneal opacity > 0.5; or, (iii), any additional signs of damage were replaced. For eyes that are not rejected based on any of these criteria, individual eyes with a corneal thickness deviating more than 10% from the mean value for all eyes are to be rejected.



EQUILIBRATION AND BASELINE RECORDINGS
Selected eyes were incubated between 55 and 70 minutes to equilibrate them to the test system prior to dosing.
Following the equilibration period, a zero reference measurement was recorded for corneal thickness and opacity to serve as a baseline (i.e., time = 0).
The fluorescein score determined at dissection was used as the baseline measurement for that endpoint.

NUMBER OF REPLICATES : 3 replicates for treatment and positivie controls/1 replicates for negative control

NEGATIVE CONTROL USED
Physiological saline – Dutscher Batch No. 3012316

POSITIVE CONTROL USED
sodium hydroxide – Sigma, Batch No. MKBP7805V

APPLICATION DOSE AND EXPOSURE TIME
30 mg of test item and positive control (powder) for 10 seconds evenly covering the surface of the cornea.
30 µL of negative control for 10 seconds evenly covering the surface of the cornea.


OBSERVATION PERIOD : 240 minutes (observation post-treatment)

REMOVAL OF TEST SUBSTANCE
- Volume and washing procedure after exposure period: the eyes were rinsed four times with 10 mL of physiological saline

SCORING SYSTEM: scoring system as indicated in the TG was used.

DECISION CRITERIA: the decision criteria as indicated in the TG was used.

Results and discussion

In vitro

Results

Results 1

Irritation parameter:

cornea opacity score

Value:

ca. 3

Negative controls validity:

valid

Positive controls validity:

valid

Remarks on result:

other: ICE Class IV

Results 2

Irritation parameter:

fluorescein retention score

Value:

ca. 1

Negative controls validity:

valid

Positive controls validity:

valid

Remarks on result:

other: ICE class II

Results 3

Irritation parameter:

percent corneal swelling

Value:

ca. 3

Negative controls validity:

valid

Positive controls validity:

valid

Remarks on result:

other: ICE Class I

Other effects / acceptance of results:

ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: The combination of the three endpoints for the negative control, physiological saline, was 2 x I, 1 x II. Therefore, the negative control is classified as “No Category”, as expected.
- Acceptance criteria met for positive control: The combination of the three endpoints for the positive control, Sodium Hydroxide, was 3 x IV. Therefore, the positive control is classified as “Corrosive/Severe Irritant”, as expected.
The test was considered to be valid.

Any other information on results incl. tables

Combination of the 3 Endpoints: 1 x IV, 1 x II, 1 x I.

Applicant's summary and conclusion

Interpretation of results:

study cannot be used for classification

Conclusions:

In accordance with the Regulation (EC) No. 1272/2008, the results obtained under these experimental conditions lead to the category “no prediction can be made”, as defined by the OECD guideline No.438. Therefore, the test item is not predicted as causing serious eye damage (Category 1) or as not classified for eye irritation/serious eye damage (No category) with the Isolated Chicken Eye test method.

Executive summary:

The aim of the study was to evaluate the possible ocular corrosive or severe irritating effects of the test item after administration on enucleated chicken eyes.

The test item was applied, as supplied, at the dose of 30 mg, to 3 enucleated chicken eyes, during 10 seconds. Then the eyes were rinsed four times with 10 mL of physiological saline. Three eyes were treated in the same manner with a positive control and one eye with a negative control. Damages by the test item were assessed by determination of corneal swelling, opacity, and fluorescein retention at 30, 75, 120, 180 and 240 minutes post-dose. The experimental protocol was established in accordance with the O.E.C.D. Test Guideline No. 438 adopted 26 July 2013 and the test method B.48 – Commission Regulation (EU) No. 1152/2010 dated 08 December 2010 (EU Journal L324) - ATP Council regulation No. 440/2008 of 30 May 2008 (E.U. Journal L142).

The ocular reactions observed in eyes treated with the test item were:

- maximal mean score of corneal opacity: 3.0, corresponding to ICE class IV;

- mean score of fluorescein retention: 1.0, corresponding to ICE class II;

- maximal mean corneal swelling: 3%, corresponding to ICE class I.

The combination of the three endpoints for the test item was 1 x IV, 1 x II, 1 x I.

The combination of the three endpoints for the positive control, Sodium Hydroxide, was 3 x IV.

Therefore, the positive control is classified as “Corrosive/Severe Irritant”, as expected.

The combination of the three endpoints for the negative control, physiological saline, was 2 x I, 1 x II.

Therefore, the negative control is classified as “No Category”, as expected.

In accordance with the Regulation (EC) No. 1272/2008, the results obtained under these experimental conditions lead to the category “no prediction can be made”, as defined by the OECD guideline No.438. Therefore, the test item is not predicted as causing serious eye damage (Category 1) or as not classified for eye irritation/serious eye damage (No category) with the Isolated Chicken Eye test method.